Targeted antioxidant properties of N-[(tetramethyl-3-pyrroline3-carboxamido)propyl] phthalimide and its nitroxide metabolite in preventing postischemic myocardial injury
Ra. Shankar et al., Targeted antioxidant properties of N-[(tetramethyl-3-pyrroline3-carboxamido)propyl] phthalimide and its nitroxide metabolite in preventing postischemic myocardial injury, J PHARM EXP, 292(3), 2000, pp. 838-845
Citations number
37
Categorie Soggetti
Pharmacology & Toxicology
Journal title
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
We investigated the cardioprotective efficacy of a new compound based on 2,
2,5,5-tetramethyl-3-pyrroline-3-carboxamide (TPC-NH). Biochemical studies u
sing electron paramagnetic resonance (EPR) spectroscopy suggest that TPC-NH
is a scavenger of reactive oxygen species. In vitro cellular studies show
that TPC-NH protects isolated cardiomyocytes against oxidative damage cause
d by superoxide radicals. Ex vivo EPR studies on the isolated rat heart ind
icate that the TPC-NH is metabolically oxidized to the nitroxide form. Stud
ies were also performed in the isolated rat heart model to measure the effi
cacy of TPC-NH and its metabolites in preventing postischemic reperfusion i
njury. Serial measurements of contractile function were performed on hearts
subjected to ischemia-reperfusion. Hearts were either untreated or treated
with 50 mM TPC-NH or with its metabolites for 1 min before ischemia and du
ring the first 5 min of reflow. TPC-NH showed marked protection with a more
than 3-fold increased recovery of contractile function compared with contr
ol hearts, whereas its oxidative metabolites exhibited significant but lowe
r protection. Thus, TPC-NH and, to a lesser extent, its oxidation metabolit
es exhibit potent membrane-targeted antioxidant action and exert marked pro
tection against myocardial injury in the postischemic heart.